The Challenge of Defining Sensitive Eligibility Criteria for Lung Cancer Screening in Populations With Low - Top-Institutions - MDSpire

Navigating the Complexities of Establishing Sensitive Criteria for Lung Cancer Screening in Low-Risk Populations

  • By

  • Mattias Johansson

  • Xiaoshuang Feng

  • July 21, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    US National Lung Screening Trial
    US National Lung Screening Trial

    Bethesda, MD

    Key Differentiators

    • Lung Cancer Screening

  • #2

    National Cancer Institute
    National Cancer Institute

    Bethesda, MD

    Key Differentiators

    • Cancer Research

  • #3

    American Cancer Society
    American Cancer Society

    Atlanta, GA

    Key Differentiators

    • Cancer Guidelines

  • #4

    U.S. Preventive Services Task Force
    U.S. Preventive Services Task Force

    Rockville, MD

    Key Differentiators

    • Preventive Services

  • #5

    Lung Cancer Alliance
    Lung Cancer Alliance

    Washington, DC

    Key Differentiators

    • Advocacy

Original Source(s)

The Challenge of Defining Sensitive Eligibility Criteria for Lung Cancer Screening in Populations With Low

  • by Mattias Johansson, Xiaoshuang Feng

  • July 21, 2026

Related Content

Case Report: Short-term disease control with subsequent icotinib therapy in EGFR L858R/C797S, T790M-negative lung adenocarcinoma after osimertinib resistance

Stereotactic versus hippocampal avoidance whole-brain radiotherapy combined with immune checkpoint inhibitors for multiple brain metastases in non-small cell lung cancer: a multi-center retrospective study

Screening Eligibility and Survival Among Patients With Lung Cancer in Korea